COPD Treatment

Links shared publicly online about this topic

New, Collaborative COPD Treatment Guidelines

copd.about.com — “New, Collaborative COPD Treatment GuidelinesView full resource at copd.about.com

  • View Related
  • Share

Most Recently Shared on August 18, 2011 at 8:05 pm By:

AboutCOPD AboutCOPD Nurse

Deborah Trendel-Lead New, Collaborative COPD Treatment Guidelines: Four physician organizations -- the American ... http://t.co/2a13IyT

6 months ago...

COPD Treatments and Management to Improve Your Lifestyle

webmd.com — “COPD treatment: It's about improving your quality of life. Get control of your COPD symptoms with these treatment options.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on September 13, 2011 at 8:35 pm By:

LungUtah American Lung Utah Health Organization

Have COPD? Or know someone who does? Read about some tips to improve quality of life while living with COPD http://t.co/zSFE8ov

5 months ago...

New COPD Treatment: Blood Pressure Medication? |

decodedscience.com — “Losartan, a common blood-pressure drug, may help prevent and treat lung damage from tobacco smoke, providing a boon to COPD sufferers.View full resource at decodedscience.com

  • View Related
  • Share

Most Recently Shared on December 20, 2011 at 2:03 pm By:

Study identifies new target for asthma and COPD treatment

european-lung-foundation.org — “A new study has identified a molecule in the body that leads to inflammation and restructure in the airways, which contributes to a number of lung conditions including chronic asthma and chronic ...View full resource at european-lung-foundation.org

  • View Related
  • Share

Most Recently Shared on April 20, 2011 at 5:45 pm By:

rtcave Rick Frea Health Professional and Patient Expert

Study identifies new target for asthma and COPD treatment http://t.co/inaIz4x via @AddThis

10 months ago...

COPD Condition Information, COPD Treatment Information and COPD Support Group

healthcentral.com — “Find information on COPD Treatment and COPD Management; Find support for COPD caregivers and patientsView full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on July 13, 2010 at 5:37 pm By:

COPD Treatment a Clinical Trial Success | www.dailyrx.com

dailyrx.com — “COPD Treatment a Clinical Trial Success | www.dailyrx.comView full resource at dailyrx.com

  • View Related
  • Share

Most Recently Shared on December 11, 2011 at 2:08 am By:

wheezemd Michael Blaiss, MD Physician, Doctor, and Allergist

Glycopyrrolate had positive results in phase 2b clinical trials in COPD http://t.co/yrC4IhB2

2 months ago...

Novartis cleared by EC for a COPD treatment - MarketWatch

marketwatch.com — “TEL AVIV (MarketWatch) -- Novartis, the Basel drugmaker, said on Thursday that the European Commission approved Onbrez in 150- and 300-microgram doses as a once-daily bronchodilator treatment for airflow obstruction in adults who suffer from chronic obstructive pulmonary disease. The product contains the active ingredient indacaterol maleate, Novartis said. COPD, which impairs lung function and causes chronic breathlessness, affects 210 million people worldwide and as many as 82 million of them View full resource at marketwatch.com

  • View Related
  • Share

Most Recently Shared on December 3, 2009 at 4:09 pm By:

New COPD Treatments Needed, Expert Says : Internal Medicine News

internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice treView full resource at internalmedicinenews.com

  • View Related
  • Share

Most Recently Shared on November 28, 2011 at 9:33 pm By:

MedicalNewsNet Bob Finn - Medical News Net Health News

Current treatments for chronic obstructive pulmonary disease can leave many patients with unmet needs - http://t.co/baaJ0Ez5

2 months ago...

Nycomed Announces REACT Study To Evaluate Impact Of Daxas(R) (roflumilast) In Patients Receiving Standard COPD Treatment

medicalnewstoday.com — “Nycomed announced plans for an international phase III/IV study investigating the effect of Daxas® (500mcg tablets, once daily) versus placebo on exacerbation rates in COPD patients who are coView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 30, 2011 at 4:05 pm By:

mnt_copd MNT COPD News Health News

Nycomed Announces REACT Study To Evaluate Impact Of Daxas(R) (roflumilast) In Patients Receiving Standard COPD Treatment http://mnt.to/3SVT

10 months ago...

Virtual lung models set to personalise asthma and COPD treatment - QualityPoint Technologies

qualitypointtech.net — “University of Leicester leads international project to develop pioneering tool A team of international experts, led by a University of Leicester researcher based at Glenfield Hospital, is set to develop a pioneering tool to help tailor the treatment of asthma and chronic obstructive pulmonary disease (COPD) as part of a new EU project.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on May 19, 2011 at 10:00 am By:

MedicalFeed MedicalFeed Health News Feed

Virtual lung models set to personalise asthma and COPD treatment: University of Leicester leads international proj... http://bit.ly/joPoq2

9 months ago...

Novartis Faces Questions About Safety Of COPD Treatment | Markets | Minyanville.com

minyanville.com — “The company hopes to win approval for two dosing levels of inhaler for chronic disease. Safety concerns may trip up the panel of government advisers next week.View full resource at minyanville.com

  • View Related
  • Share

Most Recently Shared on March 5, 2011 at 6:28 am By:

RADFoundation Bart & Tara Health Organization

Novartis prepares for FDA meet on new #COPD medicine, Arcapta http://t.co/CM92ybG

11 months ago...

Medical News: Early-Stage COPD Treatment Justified, Researchers Say - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “Treatment with the long-acting inhaled bronchodilator tiotropium (Spiriva) appears to be beneficial for patients with early-stage chronic obstructive pulmonary disease, researchers found.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 28, 2009 at 3:28 pm By:

medpagetoday MedPage Today Health News

Use of long-acting bronchodilator tiotropium (Spiriva) appears to be beneficial for patients with early-stage COPD. http://bit.ly/gAysb

2 years ago...

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment - Drugs.com MedNews

drugs.com — “New class of dual action long-acting Muscarinic Antagonist Beta-2 Agonist (MABA) has potential to change the paradigm of COPD treatment Almirall is aiming at stView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on April 11, 2011 at 7:08 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Dise... http://bit.ly/epp6MS #drug

10 months ago...

Entest BioMedical Files Patent Application On Chemokine Technology To Increase Efficacy Of Tissue-Specific Stem Cell Homing In COPD Treatment

medicalnewstoday.com — “Entest BioMedical Inc. (OTCBB: ENTB) announced the filing of a patent application covering the use of stem cell attracting molecules called chemokines in the treatment of Chronic Obstructive PulmView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 25, 2010 at 1:15 pm By:

mnt_asthma MNT Asthma News Health News

Entest BioMedical Files Patent Application On Chemokine Technology To Increase Efficacy Of Tissue-Specific Stem Cell H... http://mnt.to/3zpL

2 years ago...

Experimental Treatment for COPD in Development

jhsph.edu — “Researchers have developed a non-steroid based strategy for improving the lung--™s innate immune defense and decreasing inflammation that can be a problem for patients with chronic obstructive pulmonary disease (COPD).View full resource at jhsph.edu

  • View Related
  • Share

Most Recently Shared on April 13, 2011 at 8:12 pm By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • AboutCOPD

    AboutCOPD

    RN, freelance health writer, journalist, medical writer, passionate about COPD, About.com Guide to COPD

    View Profile

  • LungUtah

    American Lung Utah

    Committed to preventing lung disease and promoting lung health through education, research, and advocacy here in Utah and nationwide.

    View Profile

  • wheezemd

    Michael Blaiss, MD

    Allergist. Past President of the American College of Allergy, Asthma, and Immunology

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390